SCHEMBL6152936

SCHEMBL6152936

CCOC(=O)C(C#N)C1(c2cccc(SC)c2)CCN(C(=O)O)CC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 2/20 0.37
OPRD1 P41143 8/20 0.35
OPRM1 P35372 7/20 0.35
OPRK1 P41145 7/20 0.35
SLC22A1 O15245 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35
KCNH2 Q12809 1/20 0.35
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
APP P05067 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
KCNA3 P22001 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3528183 0.88 KDM4E (0.41) LMNAKDM4EOPRD1OPRK1
SCHEMBL6264708 0.86 OPRM1 (0.43) OPRD1OPRM1OPRK1SLC22A1SLC6A4
SCHEMBL3525986 0.85 KMT2A (0.48) OPRD1OPRM1OPRK1SLC22A1SLC6A4
SCHEMBL17078046 0.79 OPRM1 (0.44) LMNAOPRM1ALDH1A1SMN1; SMN2APP
SCHEMBL3527223 0.78 OPRM1 (0.38) MAPTOPRD1OPRM1OPRK1SLC6A4
SCHEMBL3523983 0.78 CRHBP (0.41) LMNAKDM4EMAPTALDH1A1HPGD
SCHEMBL3527253 0.78 TSHR (0.44) OPRD1OPRK1
SCHEMBL3529464 0.77 APP (0.47) MAPTOPRD1OPRM1OPRK1SLC22A1
SCHEMBL3523767 0.76 JAK1 (0.45) MAPTOPRD1OPRK1
SCHEMBL3526604 0.75 GRM5 (0.36) KDM4EMAPTOPRD1OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569646-A2 PIPERIDINE DERIVATIVES AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2005-09-07 EP disclosed
WO-2004054974-A2 PIPERIDINE DERIVATIVES AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2004-07-01 WO disclosed